Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 59, Number 7, October 08, 2002
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Straussberg, R.
Right arrow Articles by Amir, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Straussberg, R.
Right arrow Articles by Amir, J.
Related Collections
Right arrow All Movement Disorders
Right arrow All Pediatric
Right arrow Clinical trials Observational study (Cohort, Case control)

Neurology 2002;59:983-989
© 2002 American Academy of Neurology


Views & Reviews

Familial infantile bilateral striatal necrosis

Clinical features and response to biotin treatment

R. Straussberg, MD, Z. Shorer, MD, R. Weitz, MD, L. Basel, MD, L. Kornreich, MD, C. I. Coire, MD, L. Harel, MD, R. Djaldetti, MD and J. Amir, MD

From the Neurogenetics Clinic (Drs. Straussberg and Basel) and Departments of Pediatrics C (Drs. Straussberg, Harel, and Amir), Neurology (Drs. Straussberg and Weitz), and Radiology (Dr. Kornreich), Schneider Children’s Medical Center of Israel, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Child Neurology (Dr. Shorer), Soroka Medical Center, Ben Gurion University, The Negev, Beer Sheba; and Departments of Pathology (Dr. Coire) and Neurology (Dr. Djaldetti), Rabin Medical Center, Beilinson Campus, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Address correspondence and reprint requests to Dr. Rachel Straussberg, Neurogenetic Clinic, Department of Neurology, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel 49202; e-mail: rachelst{at}post.tau.ac.il

Background: Infantile bilateral striatal necrosis (IBSN) encompasses several syndromes of bilateral symmetric, spongy degeneration of the caudate nucleus, putamen, and globus pallidus. The familial form of IBSN is rare, and inheritance is either autosomal recessive or maternal.

Method: The authors describe an Israeli Bedouin kindred in which 15 children born to consanguineous parents were affected with familial IBSN. They evaluated the clinical and radiologic evolution of the disease in 11 patients and the cerebral pathologic findings in one patient. Three of the children were treated with oral biotin 100 mg/day.

Results: Inheritance was apparently autosomal recessive. The untreated children had a similar clinical picture including developmental arrest beginning at the age of 7 to 15 months, choreoathetosis, and dysphagia. Pendular nystagmus appeared at a late stage. MRI, performed at various stages of the disease, showed severe basal ganglia atrophy. Postmortem study in one patient showed severe atrophy of the lenticular nuclei with gliosis and loss of neurons. Biotin, 100 mg/day, administered to the proband over a period of 15 months, may have slowed progression. In two other children treatment was initiated earlier and appeared to arrest or improve disease.

Conclusions: Familial infantile bilateral striatal necrosis was inherited as an autosomal recessive trait. Clinical features included developmental arrest, dysphagia, and choreoathetosis. Imaging and pathology showed atrophy and degeneration of the basal ganglia. Oral biotin may have benefited three children.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Perez-Monjaras, R. Cervantes-Roldan, I. Meneses-Morales, R. A. Gravel, S. Reyes-Carmona, S. Solorzano-Vargas, A. Gonzalez-Noriega, and A. Leon-Del-Rio
Impaired Biotinidase Activity Disrupts Holocarboxylase Synthetase Expression in Late Onset Multiple Carboxylase Deficiency
J. Biol. Chem., December 5, 2008; 283(49): 34150 - 34158.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Morava, L. van den Heuvel, F. Hol, M. C. de Vries, M. Hogeveen, R. J. Rodenburg, and J.A.M. Smeitink
Mitochondrial disease criteria: Diagnostic applications in children
Neurology, November 28, 2006; 67(10): 1823 - 1826.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
S. Orcesi, K. Gorni, C. Termine, C. Uggetti, P. Veggiotti, F. Carrara, M. Zeviani, A. Berardinelli, and G. Lanzi
Bilateral Putaminal Necrosis Associated With the Mitochondrial DNA A8344G Myoclonus Epilepsy With Ragged Red Fibers (MERRF) Mutation: An Infantile Case
J Child Neurol, January 1, 2006; 21(1): 79 - 82.
[Abstract] [PDF]


Home page
BrainHome page
C. B. R. Funk, A. N. Prasad, P. Frosk, S. Sauer, S. Kolker, C. R. Greenberg, and M. R. Del Bigio
Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort
Brain, April 1, 2005; 128(4): 711 - 722.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.